Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Sep;40(3):199–202. doi: 10.1111/j.1365-2125.1995.tb05775.x

Pharmacoeconomics: a challenge for clinical pharmacologists.

T Walley 1, P Davey 1
PMCID: PMC1365097  PMID: 8527279

Full text

PDF
199

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chaput de Saintonge D. M., Kirwan J. R., Evans S. J., Crane G. J. How can we design trials to detect clinically important changes in disease severity? Br J Clin Pharmacol. 1988 Oct;26(4):355–362. doi: 10.1111/j.1365-2125.1988.tb03392.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Crooks J. Drug epidemiology and clinical pharmacology: their contribution to patient care. Br J Clin Pharmacol. 1983 Oct;16(4):351–357. doi: 10.1111/j.1365-2125.1983.tb02177.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davey P., Rutherford D., Graham B., Lynch B., Malek M. Repeat consultations after antibiotic prescribing for respiratory infection: a study in one general practice. Br J Gen Pract. 1994 Nov;44(388):509–513. [PMC free article] [PubMed] [Google Scholar]
  4. De Vries T. P. Presenting clinical pharmacology and therapeutics: general introduction. Br J Clin Pharmacol. 1993 Jun;35(6):577–579. doi: 10.1111/j.1365-2125.1993.tb04184.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Detsky A. S. Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada. Pharmacoeconomics. 1993 May;3(5):354–361. doi: 10.2165/00019053-199303050-00003. [DOI] [PubMed] [Google Scholar]
  6. Drummond M. F. Economic evaluation of pharmaceuticals: science or marketing? Pharmacoeconomics. 1992 Jan;1(1):8–13. doi: 10.2165/00019053-199201010-00004. [DOI] [PubMed] [Google Scholar]
  7. Greenberg E. R., Chute C. G., Stukel T., Baron J. A., Freeman D. H., Yates J., Korson R. Social and economic factors in the choice of lung cancer treatment. A population-based study in two rural states. N Engl J Med. 1988 Mar 10;318(10):612–617. doi: 10.1056/NEJM198803103181006. [DOI] [PubMed] [Google Scholar]
  8. Hurley S. F. Indices of therapeutic outcome in pharmacoeconomic evaluation of drug therapy. Pharmacoeconomics. 1992 Mar;1(3):155–160. doi: 10.2165/00019053-199201030-00002. [DOI] [PubMed] [Google Scholar]
  9. MacDonald T. M., Collins D., McGilchrist M. M., Stevens J., McKendrick A. D., McDevitt D. G., Davey P. G. The utilisation and economic evaluation of antibiotics prescribed in primary care. J Antimicrob Chemother. 1995 Jan;35(1):191–204. doi: 10.1093/jac/35.1.191. [DOI] [PubMed] [Google Scholar]
  10. Ramsay L. E. Bridging the gap between clinical pharmacology and rational drug prescribing. Br J Clin Pharmacol. 1993 Jun;35(6):575–576. doi: 10.1111/j.1365-2125.1993.tb04183.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Walley T. Drugs, money and society. Br J Clin Pharmacol. 1995 Apr;39(4):343–345. doi: 10.1111/j.1365-2125.1995.tb04461.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Walley T., Edwards R. T. Health economics in primary care in the UK: containment of drug costs. Pharmacoeconomics. 1993 Feb;3(2):100–106. doi: 10.2165/00019053-199303020-00003. [DOI] [PubMed] [Google Scholar]
  13. Walley T. Rational prescribing in primary care--a new role for clinical pharmacology? Br J Clin Pharmacol. 1993 Jul;36(1):11–12. doi: 10.1111/j.1365-2125.1993.tb05884.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES